DiseasesHair Loss — What Is Your Body Trying to Tell You?
- Henryk Różański — witasteryna F, czyli witamina F
- Henryk Różański — Capitavit – preparat płynny do pielęgnowania włosów
- Robert Brzoza — Czy krótkie włosy u kobiety to bunt wobec Boga? Dlaczego mężczyźni zakrywali głowy? - część 4
- Henryk Różański — Zioła podczas wędrówki, część I
- Henryk Różański — Wyka płotowa – Vicia sepium Linne w fitoterapii.
- Henryk Różański — Pollen, czyli pyłek
- Henryk Różański — Epimedium jako zioło poprawiające percepcję wrażeń, usprawniające zdolności poznawcze i jako alternatywa dla sildenafilum
- Henryk Różański — Pfaffiae paniculatae Radix–brazylijski żeń-szeń; Sumawurzel = Brasilianischer Ginseng jako antiphlogisticum, analgeticum et antitumor.
- Henryk Różański — Szarłat – Amaranthus raz jeszcze.
- Henryk Różański — Czy łopian Arctium lappa L. działa?
- Henryk Różański — Gorczycznik pospolity – Barbarea vulgaris R. Brown jako depurativum et diureticum. Świetny też dodatek do szamponów.
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials. · Naunyn Schmiedebergs Arch Pharmacol 2025
- Complementary and alternative medicine for alopecia areata: A systematic review. · J Am Acad Dermatol 2023
- Jiawei Erzhiwan Ameliorates Androgenetic Alopecia by Regulating the SIRT1/JNK/p38 MAPK Pathway. · Drug Des Devel Ther 2025
- Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. · Int J Immunopathol Pharmacol 2012
- [Not Available]. · Phytother Res 2020
- A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair. · J Drugs Dermatol 2018
- Buyiniuxi pill promotes hair regrowth in a DHT-induced mouse model of androgenetic alopecia. · J Ethnopharmacol 2026
- Hair Growth-Promoting Effect of a Horse Oil-Folium Isatidis Topical Preparation via Modulation of VEGF, TGF-β1, and β-Catenin Signaling in C57BL/6 Alopecia Mice: A Pilot Study. · Curr Issues Mol Biol 2026
- Yangxuebushen Decoction prevents cyclophosphamide-induced hair loss by inhibiting hair follicle apoptosis. · Cutan Ocul Toxicol 2026
Henryk Różański points out that a vitamin F deficiency may cause hair loss.
- Robert Brzoza lists age, illness, and treatment as possible causes of hair loss.
- Różański says that ingredients in calendula and hops may reduce the effects of androgens on hair.
- The methods mentioned include herbal rinses, topical rubs, and pollen taken at a dose of 1–2 teaspoons daily for one month.
What the authors write
A vitamin F deficiency may cause hair loss.
Ingredients in calendula and hops may reduce the effects of androgens on hair and prevent androgenetic alopecia.
Hair loss may be related to age, illness, or treatment.
Rinsing the hair with an infusion of burdock or mugwort is given as a way to address hair loss.
A rub-on mixture is described as a preparation for baldness, dandruff, and brittle hair.
Capitavit contains extracts from several plants and is described as a product for caring for the scalp and hair.
Capitavit can be rubbed in before washing the hair or after washing it.
Pollen is listed as a treatment for hair loss, taken at a dose of 1–2 teaspoons daily for one month.
A hair rub made from tinctures of epimedium, nettle, and Japanese katsura is described as a way to treat baldness and improve scalp circulation.
The root tincture can be diluted with water and used to rinse the hair.
An amaranth infusion is given for rinsing hair in cases of hair loss, brittleness, and lack of shine.
A decoction, shampoo containing burdock, and juice from its root were used to wash or rinse hair affected by hair loss.
Adding mustard green tincture to shampoo is described as a way to address hair loss and weak hair roots.
Research from PubMed · Europe PMC
We selected 9 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 318.
The review found that clinical studies linked some herbs with greater hair growth and density and less hair loss, although better research is needed.
Aim of the study: Hair loss is a distressing problem that affects the self-image and quality of life of many people. The increasing demand for alternative treatments has led to growing interest in using herbal medicine for hair loss management.
Results: The second part presents a systematic review of sixteen randomized controlled trials evaluating the clinical efficacy and safety of herbal remedies for hair loss. Natural products such as rosemary, green tea, ginseng, Aloe vera, olive, and saw palmetto have shown promising efficacy in promoting hair growth, improving hair density, reducing hair shedding, and enhancing patient satisfaction through mechanisms involving anti-inflammatory effects, hormonal effects, and improved scalp circulation. However, limitations in study design and variability in outcomes mean that further rigorous, standardized research is needed. This review aims to offer an integrative, evidence-informed perspective on the therapeutic potential of herbal medicine for hair loss, based on clinical evidence.
“Not stated” does not mean nobody paid — the database does not always record it.
The review found that aromatherapy with essential oils, topical garlic, and oral peony glucosides with glycyrrhizin had the best evidence for improving hair growth in alopecia areata.
Aim of the study: Despite the high use of complementary and alternative medicine (CAM) for alopecia areata (AA), its efficacy and safety remain unclear. This study aimed to identify all CAM therapies studied for treating AA. Outcomes of interest included the course of the disease and psychological well-being.
Results: Of 1015 initial citations, 16 articles met the inclusion criteria: 5 randomized controlled trials, 5 prospective controlled cohorts, 4 prospective noncontrolled cohorts, 1 retrospective cohort, and 1 case series. CAM therapies with the best evidence and efficacy for hair growth in AA include essential oil aromatherapy, topical garlic, and oral peony glucosides with compound glycyrrhizin. Hypnosis and mindfulness psychotherapy offer low-quality evidence for improving psychological and quality-of-life outcomes. Adverse events were rare and mild for all therapies evaluated. This work aims to inform physicians treating patients with AA who seek CAM, while encouraging further investigation into these therapies to address some of the treatment challenges of AA.
“Not stated” does not mean nobody paid — the database does not always record it.
In a mouse model of androgenetic alopecia, the herbal preparation Jiawei Erzhiwan supported hair regrowth and hair follicle regeneration.
Aim of the study: Androgenetic alopecia (AGA) is a type of hair loss. Our previous study showed that a water extract of an herbal prescription, "Jiawei Erzhiwan" (WJWE), derived from the traditional formula "Erzhiwan," could improve AGA. However, the underlying mechanisms are still unknown.
Results: WJWE promoted hair growth and hair follicle regeneration in AGA mice, improved DPC growth, and dose-dependently protected DPC viability reduced by DHT in vitro by stimulating the Wnt5A/β-Catenin pathway. Additionally, WJWE reduced DHT-induced oxidative stress in the skin of AGA model mice and in DHT-treated DPCs. To clarify the regulatory mechanism, we found that WJWE treatment significantly and dose-dependently increased SIRT1 expression and reduced JNK and p38 MAPK phosphorylation in both DHT-treated DPCs and AGA model mice. EX527, a SIRT1 inhibitor, could block the effect of WJWE. Our study provides some evidence for the use of WJWE to treat AGA, with the SIRT1/JNK/p38 MAPK signaling pathway potentially serving as the main target.
“Not stated” does not mean nobody paid — the database does not always record it.
In a two-year study, Serenoa repens improved hair growth in some men with androgenetic alopecia, although finasteride worked more often.
Aim of the study: The objective of this open-label study was to determine the effectiveness of Serenoa repens in treating male androgenetic alopecia (AGA), comparing its results with finasteride. For this purpose, we enrolled 100 male patients with clinically diagnosed mild to moderate AGA.
Results: 66%), with level II and III alopecia. We can summarize our results by observing that Serenoa repens could lead to an improvement in androgenetic alopecia, while finasteride confirmed its efficacy. We also observed clinically that finasteride acts on both the frontal area and the vertex, while Serenoa repens acts mainly on the vertex. Further studies will clearly be needed to clarify the mechanisms behind the different responses to these two treatments.
“Not stated” does not mean nobody paid — the database does not always record it.
A small pilot study found that a supplement containing pea sprout extract reduced hair loss after 28 days.
Aim of the study: Hair loss affects millions of people worldwide, but currently available treatment options are often unsatisfactory because of side effects or limited efficacy. Pea sprout extract has been shown to improve hair density when applied topically, but its mode of action and effectiveness when taken orally remain unknown.
Results: Additionally, a subsequent pilot nutrition intervention study in 21 volunteers showed that pea sprout extract is also effective when consumed as a dietary supplement. Daily intake of 100 mg of pea sprout extract (AnaGain™ Nu) for 8 weeks significantly reduced hair loss after just 28 days of treatment (p < 0.002). No adverse events were reported. Therefore, pea sprout extract may be an effective way to safely promote hair growth and reduce hair loss in people experiencing excessive hair shedding.
“Not stated” does not mean nobody paid — the database does not always record it.
In a randomized study, a supplement containing plant extracts increased hair counts and improved assessments of hair growth and quality compared with placebo.
Results: This nutraceutical supplement safely and effectively promoted hair growth in women who perceived their hair to be thinning. It offers a multi-targeted approach to hair loss by addressing micro-inflammation, stress, and oxidative damage with clinically tested, standardized, and bio-optimized phytoactive ingredients. ClinicalTrials.gov: NCT03206567 J Drugs Dermatol. 2018;17(5):558-565.
“Not stated” does not mean nobody paid — the database does not always record it.
In a mouse model, the herbal formula Buyiniuxi alleviated DHT-induced inhibition of hair growth.
Aim of the study: This study aimed to evaluate the hair-regrowth-promoting effects of BYNX in a dihydrotestosterone (DHT)-induced murine model of androgenetic alopecia (AGA) and to explore its potential molecular mechanisms.
Results: UHPLC-Orbitrap-MS analysis revealed a chemically complex profile of BYNX, and representative constituents were selected for subsequent network pharmacology analysis. Predicted targets were mainly enriched in inflammation-related biological processes and the PI3K-AKT signaling pathway. In vivo, BYNX significantly alleviated DHT-induced inhibition of hair growth, as shown by increased hair length, improved hair coverage, and restoration of hair follicle morphology. These changes were accompanied by reduced IL-6 and IL-4 expression, enhanced activation of the AKT/BCL-2 signaling pathway, and increased Cyclin D1 and β-catenin expression in dorsal skin tissue. BYNX significantly promotes hair regrowth in a DHT-induced murine model of AGA. Its hair-regenerative effects were associated with changes in inflammatory responses and activation of AKT/BCL-2-related survival signaling, suggesting a multi-target regulatory pattern consistent with its traditional ethnopharmacological use.
“Not stated” does not mean nobody paid — the database does not always record it.
In a mouse study, a preparation combining horse oil and Folium Isatidis increased hair length and follicle density, and the combination had a stronger effect than either ingredient alone.
Aim of the study: Wnt/β-catenin signaling is a key regulator of hair follicle cycle progression, and abnormal activation or suppression of this pathway has been linked to the development of alopecia. Horse oil (HO) and Folium Isatidis (FI) have traditionally been used in East Asian medicine to promote hair growth, but the molecular mechanism of their combination remains unclear.
Results: All three treatments increased VEGF and β-catenin, suppressed TGF-β1, increased Bcl-2, and reduced Bax expression. HOFI had significantly greater effects than either treatment alone across all endpoints (p < 0.05). HOFI promotes hair growth by activating the VEGF/β-catenin signaling axis, inhibiting TGF-β1, and shifting the Bcl-2/Bax balance in favor of follicular cell survival. These findings provide a molecular rationale for developing HO-FI combinations as topical treatments for alopecia.
“Not stated” does not mean nobody paid — the database does not always record it.
In a mouse model of chemotherapy-induced alopecia, the YXBSD decoction supported hair regrowth and limited hair follicle damage.
Aim of the study: Alopecia is a skin condition that can impose a substantial psychological burden on affected individuals, and chemotherapy-induced alopecia remains one of the most distressing adverse effects of anticancer treatment. Since antiquity, medicinal plants have been widely used in traditional Chinese medicine to support hair growth.
Results: YXBSD significantly promoted hair growth in CYP-treated mice, improved hair follicle structure, increased the proportion of hair follicles in the growth phase (from 15% to 30%), and reduced apoptosis of hair follicle cells (from 30% to 20%). At the same time, YXBSD markedly suppressed the expression of inflammatory mediators (TNF-α, IL-6, and IL-1β) in skin tissue, decreased the oxidative stress marker malondialdehyde (MDA), and increased the activity of the antioxidant enzyme superoxide dismutase (SOD). In line with these changes, YXBSD increased the expression of the proliferation marker Ki-67 while reducing the apoptosis-related protein p53. YXBSD effectively alleviated CYP-induced alopecia by inhibiting apoptosis in hair follicle cells while also reducing inflammation and oxidative stress, thereby promoting the recovery of hair follicle structure and function. These findings suggest that YXBSD may have potential as an adjunct treatment for chemotherapy-induced alopecia.
“Not stated” does not mean nobody paid — the database does not always record it.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.